Orly Goldstein

6 Weizmann Street
Tel Aviv, TA 64239, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Large-scale functional annotation establishes a reference framework for human LRRK2 variants.

Large-scale functional annotation establishes a reference framework for human LRRK2 variants.

Journal: medRxiv : the preprint server for health sciences

Published: July 03, 2026

Effect of genetic factors on [18F]FDG PET metabolic phenotypes in dementia with Lewy bodies.

Effect of genetic factors on [18F]FDG PET metabolic phenotypes in dementia with Lewy bodies.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 26, 2026

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 18, 2026

The Effect of LRRK2 and GBA1 Mutations on Survival in Early- and Late-Onset Parkinson's Disease.

The Effect of LRRK2 and GBA1 Mutations on Survival in Early- and Late-Onset Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 13, 2026

Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.

Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.

Journal: Journal of Parkinson's disease

Published: January 23, 2026

A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

Journal: European journal of neurology

Published: January 01, 2026

Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort.

Alpha-synuclein co-pathology in a real-world early Alzheimer's disease cohort.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 06, 2025

The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.

The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriers.

Journal: Journal of Parkinson's disease

Published: February 20, 2025

P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.

P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.

Journal: Journal of Parkinson's disease

Published: February 17, 2025

TMEM16F regulates pathologic α-synuclein secretion and spread in cellular and mouse models of Parkinson's disease.

TMEM16F regulates pathologic α-synuclein secretion and spread in cellular and mouse models of Parkinson's disease.

Journal: Aging cell

Published: April 15, 2024

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: April 03, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026